[Clinical applications expected in the future--osteoporosis].
Takeshi Fujita
Abstract
Takeshi Fujita
Abstract
Severe vitamin deficiency causes osteomalacia, but osteoporosis is also associated with decreased vitamin D activity. Intestinal calcium absorption is decreased and vitamin D metabolites low in osteoporosis and cytokine and growth factor abnormalities in osteoporosis may be ascribed to vitamin D deficiency. In Japan, 1 alpha (OH) vitamin D3 and 1.25(OH)2 vitamin D3 have been used for osteoporosis with beneficial effect and scarcely any side effects for many years. World wide, the effect of vitamin D on osteoporosis is gradually recognized. The higher the dose, longer the duration of administration and older the age of the patients, more positive effects tend to be obtained.
A significance statement is not available in the OpenAlex record.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
Severe vitamin deficiency causes osteomalacia, but osteoporosis is also associated with decreased vitamin D activity. Intestinal calcium absorption is decreased and vitamin D metabolites low in osteoporosis and cytokine and growth factor abnormalities in osteoporosis may be ascribed to vitamin D deficiency. In Japan, 1 alpha (OH) vitamin D3 and 1.25(OH)2 vitamin D3 have been used for osteoporosis with beneficial effect and scarcely any side effects for many years. World wide, the effect of vitamin D on osteoporosis is gradually recognized. The higher the dose, longer the duration of administration and older the age of the patients, more positive effects tend to be obtained.
Key concepts: Osteoporosis, Osteomalacia, Vitamin D and neurology, Medicine, vitamin D deficiency, Internal medicine, Vitamin, Endocrinology